Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BenQ BM Holding CaymanHKSE:02581 -1.71%16 EBITDA Margin % is 12.72% as of Dec. 2025, which is 1% below its 10-year median of 12.88. GuruFocus rates HKSE:02581 with a GF Score™ of 16/100. The stock has 3 warning signs investors should review. Among 667 Healthcare Providers & Services companies, BenQ BM Holding Cayman ranks worse than 57.87% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
BenQ BM Holding Cayman EBITDA Margin % Related Terms
BenQ BM Holding Cayman EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for BenQ BM Holding Cayman's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02581 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, BenQ BM Holding Cayman's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BenQ BM Holding Cayman EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, BenQ BM Holding Cayman's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where BenQ BM Holding Cayman's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BenQ BM Holding Cayman (HKSE:02581) has a EBITDA Margin % of 12.72% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BenQ BM Holding Cayman and its competitors. This is near median its historical median of 12.88. Over the past decade, BenQ BM Holding Cayman's EBITDA Margin % has ranged from 7.85 to 14.81. According to the industry distribution chart, BenQ BM Holding Cayman ranks #386 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 57.9%.
Is BenQ BM Holding Cayman's EBITDA Margin % too high?
BenQ BM Holding Cayman's current EBITDA Margin % of 12.72% is near median its 10-year median of 12.88. Over the past 10 years, this metric has ranged from a low of 7.85 to a high of 14.81. The Healthcare Providers & Services industry median EBITDA Margin % is 10.23. BenQ BM Holding Cayman's value of 12.72% is 24.3% above this industry median. Based on the distribution chart, BenQ BM Holding Cayman ranks #386 out of 667 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, BenQ BM Holding Cayman has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does BenQ BM Holding Cayman's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, BenQ BM Holding Cayman ranks #386 out of 667 companies for EBITDA Margin %. This places BenQ BM Holding Cayman in the lower half of its industry. The industry median EBITDA Margin % is 10.23. BenQ BM Holding Cayman's value of 12.72% is 24.3% above this benchmark. Historically, BenQ BM Holding Cayman's own EBITDA Margin % has ranged from 7.85 to 14.81 over the past decade. While the company's 10-year median is 12.88 vs. the industry median of 10.23, BenQ BM Holding Cayman has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.23, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BenQ BM Holding Cayman's current EBITDA Margin % of 12.72% is 24.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BenQ BM Holding Cayman and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BenQ BM Holding Cayman's current EBITDA Margin % is 12.72%, which is near median its own 10-year median of 12.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ BM Holding Cayman stock overvalued right now?
BenQ BM Holding Cayman (HKSE:02581) has a current EBITDA Margin % of 12.72%. The current EBITDA Margin % is 12.72%, which is near median its 10-year median of 12.88 and 24.3% above the Healthcare Providers & Services industry median of 10.23. BenQ BM Holding Cayman's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For BenQ BM Holding Cayman (HKSE:02581), the current EBITDA Margin % is 12.72% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BenQ BM Holding Cayman Corp is a healthcare services provider focusing on the provision of medical services in Mainland China. It provides diversified medical services to patients through the operation of general hospitals, covering disease diagnosis and treatment, health management and medical support services. It operates Nanjing BenQ Hospital and Suzhou BenQ Hospital in Mainland China. Its service offerings cover outpatient services, inpatient services, surgical services and related medical support services, and extend to ancillary medical services such as laboratory testing, imaging, nursing and other supporting services built around its core medical services. It operates in single segment and generates revenue from provision of hospital healthcare services in the PRC.
16GF Score
Get the complete analysis for HKSE:02581
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02581 has been successfully added to your 
